Brief: Biosynex H1 Revenue Down 70% Due To Drop In Covid Sales

Biosynex SA

20/07/2023 18:03

July 20 (Reuters) - Biosynex SA  ALBIO.PA :
    * H1 TOTAL GROUP REVENUE EUR 42.8 MLN, DOWN 70% VS EUR 142.2
MLN
YR AGO
    * H1 COVID SALES DOWN AT EUR 4.5 MLN, VS EUR 115.5 MLN YR
AGO
    * H1 NON-COVID SALES AT EUR 38.3 MLN, UP 43.4% 
    * OUTLOOK 2023: ACCELERATION OF REVENUE GROWTH OUTSIDE COVID
    * EXPECTS ACQUIRED CHEMBIO DIAGNOSTICS INC AND PROCISEDX TO
LEVERAGE ACCELERATION OF ACTIVITIES

        
 Source text for Eikon:  ID:nEQ2gNrr4a 
 Further company coverage:  ALBIO.PA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))